Etodolac
Product Images NDC 52959-471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 52959-471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Etodolac (49f1f6a3 Ff50 4a86 Aa74 954f34d7042e 01)

Structural Formula For Etodolac (49f1f6a3 Ff50 4a86 Aa74 954f34d7042e 01)
Chemical structure of Etodolac showing its molecular framework with a bicyclic ring system, including a benzene ring and a pyran ring, and functional groups such as a carboxylic acid and an ethyl substituent.*
FDA Label Image

Etodolac Tablets Usp 400 mg 100s Label (49f1f6a3 Ff50 4a86 Aa74 954f34d7042e 02)

Etodolac Tablets Usp 400 mg 100s Label (49f1f6a3 Ff50 4a86 Aa74 954f34d7042e 02)
Etodolac 400mg tablet label showing dosage strength, lot number ETO403TV, manufacturer TEVA PHARM in Sellersville, PA, and expiration date 05/13. The label indicates comparison to Lodin and describes the tablet as a pink oval. Package quantity is 30 tablets. Caution information emphasizes prescription dispensing requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.